CLDN3 and ovarian carcinoma: Emerging evidence on the association of CSC/TICs with chemoresistance suggests that the reduced levels of claudin-3, -4, or -7 expression in ovarian cancer cells is related to increased resistance to chemotherapy based on recent studies showing that reduced claudin-3 or claudin-4 promote EMT in ovarian cancer cells [96].